Company · Ownership research

BeOne Medicines Ltd. ONC

CIK 0001651308

Form 4 transactions dated Oct 1, 2023 to Oct 15, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 33 rows; the complete set is available through the API.

Insider filings on file run through Oct 2, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $0.00
Sold: $4.79B

Oct 1, 2023 – Oct 2, 2026
Available records · partial months are marked ·

Insiders in this window

202410 of 30 preview events · 33 available in 2024

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 10, 2024	Wang Xiaodong Director · Chair, Scientific Advisory Brd	Sale10b5-1 footnote	$7.81M 41,760 shares sold	100.00% sold Direct holding	▾
Dec 9, 2024	BAKER JULIAN · BAKER FELIX · BAKER BROS. ADVISORS LP · Baker Brothers Life Sciences LP · 667, L.P. · Baker Bros. Advisors (GP) LLC Director	Sale	$194.20M 1,037,017 shares sold	Unavailable Indirect holding	▾
Dec 6, 2024	Wu Xiaobin President, COO & GM China	Sale	$0.00 0 shares sold	Unavailable Indirect holding	▾
Dec 2, 2024	HILLHOUSE INVESTMENT MANAGEMENT, LTD. · HHLR ADVISORS, LTD. 10% owner	Sale	$3.57B 17,842,500 shares sold	Unavailable Indirect holding	▾
Nov 26, 2024	Wang Xiaodong Director · Chair, Scientific Advisory Brd	Sale10b5-1 footnote	$7.69M 40,468 shares sold	100.00% sold Direct holding	▾
Nov 26, 2024	Wang Xiaodong Director · Chair, Scientific Advisory Brd	Sale10b5-1 footnote	$1.50M 7,883 shares sold	100.00% sold Indirect holding	▾
Oct 8, 2024	OYLER JOHN Chief Executive Officer · Director	Sale10b5-1 footnote	$1.43M 6,175 shares sold	100.00% sold Direct holding	▾
Oct 8, 2024	OYLER JOHN Chief Executive Officer · Director	Sale10b5-1 footnote	$2.32M 10,000 shares sold	100.00% sold Indirect holding	▾
Sep 30, 2024	Lee Chan Henry SVP, General Counsel	Sale10b5-1 footnote	$284.99K 1,202 shares sold	100.00% sold Direct holding	▾
Sep 27, 2024	Wang Lai Global Head of R&D	Sale10b5-1 footnote	$1.10M 5,000 shares sold	100.00% sold Indirect holding	▾

Showing 30 / 33 record groups in 2024. The complete set is available through the API.

BeOne Medicines Ltd. · ONC

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 33 purchase / sale groups and 30 of 43 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"ONC","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.